Breakthrough Dyspnea Fentanyl Study in Cancer Patients

NCT01515566 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancers
Dyspnea

Interventions

DRUG: Fentanyl
OTHER: Placebo
OTHER: Walking Tests
BEHAVIORAL: Questionnaires

Sponsor

M.D. Anderson Cancer Center